Product Program year 2025 Source: CMS Open Payments

BenchMark ULTRA

Device Tissue Diagnostics

PDI 04015630981052

Open in the dashboard

General payments

$339,161

294 payments

Research payments

$3,154,680

314 payments

Through program year 2025, $339,161 in general payments and $3,154,680 in research payments were reported against BenchMark ULTRA (Tissue Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $8,160 118
2025 Research $6,000 10
2024 General $4,940 80
2024 Research $245,854 25
2023 General $2,661 6
2023 Research $206,985 38
2022 General $15,074 27
2022 Research $640,626 74
2021 General $308,326 63
2021 Research $2,055,215 167

Breakdown

Who paid General payments · program years 2021–2025
  1. Ventana Medical Systems, Inc. $291,239 27 payments
  2. Roche Diagnostics Corporation $47,655 265 payments
  3. Roche Molecular Systems, Inc. $267 2 payments
Top recipients General payments · program year 2025
  1. Magdalena Czader Clinical Pathology/Laboratory Medicine · Indianapolis, IN $2,258 28% · 10 payments
  2. Michael Feldman Anatomic Pathology & Clinical Pathology · Indianapolis, IN $1,703 21% · 9 payments
  3. Chirag Patel Clinical Pathology/Laboratory Medicine · Scottsdale, AZ $1,388 17% · 4 payments
  4. Drazen Jukic Dermatopathology · Savannah, GA $177 2% · 1 payment
  5. Matthew Tilson Anatomic Pathology & Clinical Pathology · Savannah, GA $177 2% · 1 payment

The top 5 of 90 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Pathology/Laboratory Medicine Pathology $3,761 47% · 4 practitioners
  2. Anatomic Pathology & Clinical Pathology Pathology $3,496 43% · 63 practitioners
  3. Dermatopathology Pathology $310 4% · 6 practitioners
  4. Anatomic Pathology Pathology $193 2% · 10 practitioners
  5. Medical Oncology Internal Medicine $130 2% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Indiana $3,962 49% · 2 recipients
  2. Arizona $1,475 18% · 2 recipients
  3. Missouri $580 7% · 21 recipients
  4. Georgia $410 5% · 4 recipients
  5. Maryland $247 3% · 11 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

294 general · 314 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record